It is now well recognized that COVID-19 presents with an organ dominant syndromic disease in which the lungs are mostly the commonest organ being involved. Another benefit of this organ stage-based classification of the patients is that it would enable the hospital units to act in concert to anticipate complications and clinically manage the patients affected by the chronicity of COVID-19. With the ongoing pandemic of coronavirus diseases (COVID-19) caused by SARS-CoV-2, there has been a surge in research and publications related to its pathogenesis and the clinical presentation of the affected patients.[Extracted from the article]